An interventional study of combowire and IVUS in Coronary Stenosis, sponsored by Hyogo Medical University. Withdrawn at 1 site in Japan. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-08-02.
Sponsored by Hyogo Medical University · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 14 studies in Coronary Stenosis with a site in Japan — 2 open to participants now, 3 under way, none of them phase 3. Coronary Stenosis · Japan.
Among the 14 studies in Coronary Stenosis with a site in Japan, this one is the 11th largest by enrollment of the 11 interventional ones that give a count, is the only one that started in 2014, is one of 10 with no phase, and was the 8th registered.
326 studies on the registry are indexed under Coronary Stenosis; 57 are open to participants now.
Browse Coronary Stenosis studies →2 of the 14 studies in Coronary Stenosis with a site in Japan are open now. Recruiting first, the newest first:
Duk-Woo Park, MD · Sites in Japan, United States, Australia and 11 more countries
Ages 20+
Insel Gruppe AG, University Hospital Bern · Sites in Japan, France, Germany and 1 more country
Ages 18+
A study can be open while its sites in Japan have not opened yet or have stopped. Only those recruiting at a site in Japan →
Of the 40 Coronary Stenosis studies recruiting now, 33 (83%) set no upper age limit and 3 (8%) stop at 75 or younger; 4 take children under 18; 2 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
14 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2014.
Median enrollment 240 across the 11 interventional studies, 536 across the 3 observational. Of the 9 that completed or were terminated, 6 (67%) have results posted.
This tab as a report to print or save as PDF → With an account.
10 of 14 have an industry lead sponsor. The 9 most frequent:
Hyogo Medical University is the lead sponsor of 9 studies on the registry; 1 is open to participants now.
Hyogo Medical University has 1 study filed under Coronary Stenosis — fewer than ten, so there is no comparison to draw.
1 of the studies in Coronary Stenosis with a site in Japan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03820492Insel Gruppe AG, University Hospital BernComparison of Optical Coherence Tomography-derived Minimal Lumen Area, Invasive Fractional Flow Reserve and FFRCT | 2026-12-31 |
Add it to your calendar (.ics) → With an account.
Among the 14 studies in Coronary Stenosis with a site in Japan, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Subjects are patients who are planned to do percutaneous coronary intervention for coronary stenosis in the left circumflex artery without other stenosis in the left ascending artery and the right coronary artery, or a patient with normal coronary artery. Immediately after coronary angiography or percutaneous coronary intervention, the investigators will evaluate for coronary hemodynamics by distribution of wave intensity which is calcurated by coronary pressure and flow velocity with Combowire in each coronary segment. Also, they will assess coronary morphology by View It in each coronary segment.
Combowire (Volcano Therapeutics Inc., CA, USA) is a 0.014 inch pressure/Doppler sensor-tipped-guidewire which can measure coronary pressure and flow velocity.
View It (Terumo Co., Japan) is a guide catheter with intravascular ultrasound which can measure coronary morphology such as vessel diamter.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Device: combowire and IVUS
Wave intensity
Time frame: Immediately after coronary angiography or percutaneous coronary intervention
Coronary pressure
Time frame: Immediately after coronary angiography or percutaneous coronary intervention
Flow velocity
Time frame: Immediately after coronary angiography or percutaneous coronary intervention
Vessel diameter
Time frame: Immediately after coronary angiography or percutaneous coronary intervention
The record gives a start of Dec 2014, a primary completion of Feb 2017 and a completion of Feb 2017. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is withdrawn, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hyogo Medical University